Burning Rock Biotech 

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$124,571
$124,571
$131,616
$148,554
Gross Profit
97,205
97,205
98,844
108,103
EBITDA
-9,056
-9,056
-3,284
1,349
EBIT
-11,871
-11,871
-16,131
-11,497
Net Income
-15,173
-15,173
-16,758
-9,702
Net Change In Cash
124,571
124,571
131,616
148,554
Free Cash Flow
17,790
17,790
16,393
-44,349
Cash
481,394
481,394
463,994
452,721
Basic Shares
1,047
1,047
1,076
1,076

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$524,867
$515,822
$537,435
$563,238
Gross Profit
391,936
362,400
363,227
380,039
EBITDA
-43,054
-270,232
-517,901
-856,311
EBIT
-53,350
-322,432
-651,301
-980,407
Net Income
-53,838
-346,626
-653,689
-971,233
Net Change In Cash
524,867
515,822
537,435
563,238
Free Cash Flow
-33,692
-98,238
-265,167
-518,839
Cash
481,394
519,849
615,096
905,451
Basic Shares
1,078
10,293
10,239
10,390

Earnings Calls

QuarterEPS
2026-03-31
-$0.20
2025-09-30
-$1.56
2025-06-30
-$0.90
2025-03-31
-$1.25